ReachMD

Be part of the knowledge.™

Cardiology

2684

LikeLikedUnlike

Episodes 1-15 of 752

0
Heart Matters
Optimizing Pregnancy Plans & Management in Congenital Heart Disease Patients
Optimizing Pregnancy Plans & Management in Congenital Heart Disease Patients
- Alan S. Brown, MD, FACC, FAHA, FNLA
  Peer
- Dustin Sulak, DO
  Peer
1
Heart Matters
Considering Cannabis & the Cardiovascular System: A Look at Patient Outcomes
Considering Cannabis & the Cardiovascular System: A Look at Patient Outcomes
- Joseph Saseen, PharmD, BCPS, BCACP, CLS
  Peer
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
0
CME/CE
Variable Effects of Omega-3 Fatty Acids for ASCVD Event Reduction: Why?
Variable Effects of Omega-3 Fatty Acids for ASCVD Event Reduction: Why?
0.25 credits
- Alan S. Brown, MD, FACC, FAHA, FNLA
  Peer
- Heval M. Kelli, MD
  Peer
- Alan Amedi
  Peer
0
Heart Matters
Exploring the Careers of Cardiologists: A Noninvasive Cardiologist's Journey & a First-Year Student's Story
Exploring the Careers of Cardiologists: A Noninvasive Cardiologist's Journey & a First-Year Student's Story
- John Ryan, MD, MB, BCh, BAO, MRCPI, FACC, FAHA
  Peer
2
CME/CE
The ABCs of CTD-PAH: (A)lgorithms, Team-(B)ased Approach, and (C)ombination Therapy
The ABCs of CTD-PAH: (A)lgorithms, Team-(B)ased Approach, and (C)ombination Therapy
1.25 credits
- Erin D. Michos, MD, MHS, FACC, FAHA, FASE
  Peer
- Leslie Cho, MD
  Peer
1
CME/CE
Clinician’s Update on Omega-3s in ASCVD Risk Reduction
Clinician’s Update on Omega-3s in ASCVD Risk Reduction
0.25 credits
- Michael Greenberg, MD
  Peer
- Nehal N. Mehta, MD, MSCE, FAHA
  Peer
5
DermConsult
Investigating the Link Between Heart Disease Risk Factors & Psoriasis
Investigating the Link Between Heart Disease Risk Factors & Psoriasis
- Hector O. Chapa, MD
  Peer
- Marc S. Sabatine, MD, MPH
  Peer
0
CME/CE
Optimizing LDL-C Management in the Post-MI Patient
Optimizing LDL-C Management in the Post-MI Patient
0.50 credits
- George Bakris, MD
  Peer
- Biff F. Palmer, MD
  Peer
1
CME/CE
RAASi Therapy, Diabetes, and Hyperkalemia: Halting Therapy Is NOT the Only Option
RAASi Therapy, Diabetes, and Hyperkalemia: Halting Therapy Is NOT the Only Option
0.25 credits
- Alan S. Brown, MD, FACC, FAHA, FNLA
  Peer
- Nathan D. Wong, PhD, MPH
  Peer
0
Heart Matters
Cardiology Considerations for Patients with Type 2 Diabetes
Cardiology Considerations for Patients with Type 2 Diabetes
- Matt Birnholz, MD
  Peer
- April Taylor, MS, MHA, CPPS, CPHQ
  Peer
9
Vascular Viewpoints
The Risk of HAC Score Prioritization in Vascular Access Care
The Risk of HAC Score Prioritization in Vascular Access Care
- Eden Miller, DO
  Peer
- James O’Keefe, MD
  Peer
1
Medical Industry Feature
Close to the Heart: Assessing Cardiovascular Risk Factors in Our Patients With Type 2 Diabetes
Close to the Heart: Assessing Cardiovascular Risk Factors in Our Patients With Type 2 Diabetes
- Eden Miller, DO
  Peer
- James O’Keefe, MD
  Peer
1
Medical Industry Feature
Close to the Heart: The Impact of Cardiovascular Disease on Patients With Type 2 Diabetes
Close to the Heart: The Impact of Cardiovascular Disease on Patients With Type 2 Diabetes
- Amy Mackey, MD
  Peer
- Salim Rezaie, MD
  Peer
- Evan Alexandrou, MD
  Peer
11
Vascular Viewpoints
Focusing on Real-Time Catheter Tip Confirmation for Central Lines
Focusing on Real-Time Catheter Tip Confirmation for Central Lines
- Matt Birnholz, MD
  Peer
- Marcia Ryder, PhD MS RN
  Peer
8
Vascular Viewpoints
Pearls & Pitfalls of Algorithm-Based Vascular Access Care Protocols
Pearls & Pitfalls of Algorithm-Based Vascular Access Care Protocols

Programs 8/4/21

Segment Chapters

Playlist:

Recommended